SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW)
VSAT 38.61+2.4%3:50 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stock Watcher who wrote (29585)3/16/2000 4:46:00 PM
From: Andrew G.   of 52051
 
JNJ s/b a big beneficiary of genomics revolution as well as all the big pharmaceuticals.
Ultimately, they will be bringing major new product shift to market and using their financial muscle to leverage even larger profits off of the new discoveries than with 'old world' hit-or-miss drugs.

Barring a jarring from an over zealous FED rate hike next week, JNJ to +$100 territory within next 10 trading sessions with minimal downside risk. That's what I see.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News